Ring in the New Year with Exclusive Discounts from The Business Research Company! Enjoy a 33% markdown on our Opportunities and Strategies Reports and a fantastic 25% off on our Global Market Reports. Don’t miss out on this limited-time offer to gain valuable insights and stay ahead in your industry
The Business Research Company’s Acute Coronary Syndrome Global Market Report 2024 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2024-2033. The Acute Coronary Syndrome Global Market Report 2023 evaluates acute coronary syndrome market size, growth rate, drivers, trends, and major companies.
The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=12985&type=smp
The global acute coronary syndrome (ACS) market is poised for substantial growth, projecting an increase from $9.23 billion in 2023 to $9.86 billion in 2024, reflecting a noteworthy Compound Annual Growth Rate (CAGR) of 6.9%. This surge in the historical period can be ascribed to dynamic factors, including robust public health initiatives, widespread adoption of telemedicine and remote monitoring, enhanced emergency medical services, and an escalating demand for patient education.
Forecasts indicate a robust expansion in the ACS market, reaching $12.44 billion by 2028, with a CAGR of 6.0%. The driving force behind this growth is the escalating prevalence of chronic diseases such as coronary artery disease, ischemic heart disease, and vascular disorders. Ischemic heart disease, a chronic ailment resulting from coronary artery obstruction or narrowing, underscores the urgent need for effective ACS treatment.
Addressing ACS involves prompt symptom relief, minimizing heart damage, and averting complications. A notable study published in the Journal of the American College of Cardiology in August 2022, conducted by a prominent US-based organization, highlighted alarming projections for cardiovascular risk factors in the general U.S. population from 2025 to 2060. Anticipated increases of 27.6% in dyslipidemia and 25.1% in hypertension were noted, with heart failure (33.4%) and ischemic heart disease (30.7%) displaying the most significant anticipated rate hikes, followed by heart attack (16.9%) and stroke (33.8%).
In light of these findings, it becomes evident that the escalating prevalence of chronic diseases, namely coronary artery disease, ischemic heart disease, and vascular disorders, is a pivotal driver propelling the acute coronary syndrome market towards substantial expansion.
Get More Information On The Acute Coronary Syndrome Market Report:
https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report
The acute coronary syndrome market segments in the report are:
1) Acute Coronary Syndrome Market By Type: Non-St-Elevation Myocardial Infarction, St-Elevation Myocardial Infarction, Unstable Angina
2) Acute Coronary Syndrome Market By Treatment: Medications, Statins, Beta blockers, ACE inhibitors, Anticoagulants, Other Treatment
3) Acute Coronary Syndrome Market By Diagnosis: Stress Test, Blood Tests, Imaging, Other Diagnosis
4) Acute Coronary Syndrome Market By Route Of Administration: Oral, Parenteral
5) Acute Coronary Syndrome Market By End-User: Hospitals, Specialty clinics, Other End User
Top Major Players
The table of contents in TBRC’s acute coronary syndrome market report includes:
1. Executive Summary
2. Acute Coronary Syndrome Market Characteristics
3. Acute Coronary Syndrome Market Trends And Strategies
4. Acute Coronary Syndrome Market – Macro Economic Scenario
5. Global Acute Coronary Syndrome Market Size and Growth
………
32. Global Acute Coronary Syndrome Market Competitive Benchmarking
33. Global Acute Coronary Syndrome Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Acute Coronary Syndrome Market
35. Acute Coronary Syndrome Market Future Outlook and Potential Analysis
36. Appendix
Read Related Reports:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
